A new policy shift is reshaping the landscape for GLP-1 drugs, signaling major financial effects for Medicare, insurers, and ...

The unfounded accusations came after behind the scenes footage of a photoshoot Obama did with Annie Leibovitz was shared on Instagram over the weekend ...

The next-generation “GLP-1 plus” drugs will be tailored to the health needs of individual patients.

Novo Nordisk (NVO) remains a strong buy in the weight loss/diabetes market despite challenges. Read here for an investment ...

And Big Pharma’s not done cashing in on the weight-loss boom. Drugmakers are readying a new wave of next-level GLP-1 treatments, with several promising candidates in the pipeline. These experimental ...